PHOSPHATIDYLSERINE-DEPENDENT ANTI-PROTHROMBIN (APS/PT) ANTIBODIES AND ANTIPHOSPHOLIPID (APL) ANTIBODIES IN ANTI-TNF-ALPHA ANTIBODY-TREATED PATIENTS WITH INFLAMMATORY BOWEL DISEASES (IBD)
Abstract
Higher concentrations of propshatidylserine-dependent antiprothrombin antibodies (aPS/PT) IgG and IgM were found in IBD patients at the beginning of the biological treatment compared to the maintenance treatment period.